Twenty seven cases of giant cell tumor of bone were evaluated for their cell kinetics by using proliferating cell nuclear antigen (PCNA) immunoreactivity and antiproteolytic and lysozymal activities in multinucleated giant cells and mononuclear cells in order to evaluate their cellular characteristics and possible histogenesis.
The multinucleated giant cell nuclei were unlabeled by PCNA 
I. Introduction
Giant cell tumors of bone, primarily a lesion affecting long bones, are rare tumors and a number of studies to differentiate these tumors from a diverse group of giant cell lesions of bones such as giant cell reparative granuloma and aneurysmal bone cysts have shown that a number of pathological, histomorphological and immunological features demonstrate a considerable overlap between these lesions [7, 12, 18, 25, 26, 28, 36, 38, 40, 41] . Giant cell lesions, in patients with hyperparathyroidism and cherubism, are well defined entities in which the natural history and prognosis are predictable.
The nature of other giant cell lesions, on the other hand, are uncertain and may demonstrate variable clinical and histopathological features and may tend to show benign to aggressive behavior, recurrence and not quite infrequently metastases. Studies on the pathobiology of giant cell tumors may therefore provide a rational basis to understand or predict the clinical behavior and novel application of therapeutic regimens which at present confer a considerable dilemma in diagnosis and management.
The histogenesis and pathological significance of giant cells in giant cell tumors are far from clear. Multinucleated giant cells have been suggested to arise from mononuclear cells [13, 16, 39] , macrophages [17] , osteoclasts [2] or form a mixed population of these cells. The present study evaluates cell kinetics of giant cell tumors using proliferating cell nuclear antigen (PCNA), a of lysozyme was seen in the cytoplasm of multinucleated giant cells, particularly stronger in the perinuclear area ( Fig.1-E,  F) . Necrotic multinucleated giant cells were unreactive for lysozymes.
The alpha-1 antitrypsin and alpha-1 antichymotrypsin immunoreactivities were heterogeneous, and some multinucleated giant cells showed intense immunoreactivity for alpha-1 antitrypsin and alpha-1 antichymotrypsin. Fine granular deposition in multinucleated giant cells cytoplasm was observed except for the perinuclear area. The histiocyte-like cells were more often positive than fibroblast-like cells (Fig.2-A, B, C, D and Fig.3-A, B, C) .
Lactoferrin immunoreactivity was found in a few mononuclear cells and not in multinucleated giant cells.
Immunohistochemical results of GCT of bone are shown in Table3.
IV. Discussion
Cell kinetic information is becoming increasingly important as a potential prognostic indicator in cancer treat- Fig.2 ment and as a method for evaluating response to treatment [3, 6, 11, 30, 31, 37] . Proliferating cell nuclear antigen (PCNA) is one such proliferation marker; a 36 KD protein identified as an auxiliary protein of DNA polymerase [4] . Its distribution in the cell cycle, increasing through G1, peaking at the G1/S-phage interface, decreasing through G 2, and reaching low levels which are virtually undetectable by immunocytochemical methods in M-phase and quiescent cells, make it a useful marker for proliferating cells [19, 20, 33] . It has been reported that the PCNA labelling index correlates with histological grade [1] and with growth fraction data obtained using flow cytometry and the Ki67 labelling index [8, 10, 23] . However, numerous investigators have reported that the PCNA labelling index does not correlate with grading in breast cancers [22] and glioblastoma [9] . This is the first study of PCNA immunohistochemistry in giant cell tumor of bone.
We found that giant cells are not labelled by PCNA, and it may be suggested that these giant cells do not undergo cellular division and the mononuclear cells were the major proliferating cells in GCT of bone. It has been accepted that histopathologic grading of giant cell tumor of bone by Jaffe not paralel for clinical behavers, and now we have not used such criteria of pathologic grading.
We also found that there was no association between PCNA labelling index and histological grading devised by Jaffe. A number of investigators reported that histologic grade, based on variations of mononuclear and giant cells may not help predict the likelihood of recurrence of GCT [12, 21, 32, 40] .
Lysozyme, alpha-1 antitrypsin and alpha-1 antichymotrypsin are usually regarded as enzyme markers for normal or reactive mononuclear macrophages. These lysozyme positive cells may be regarded as mature mononuclear macrophages and as representing an immunologic reaction of the host tissue against the tumor [15, 27, 29, 34] . A population of multinucleated giant cells showed a similar profile of distribution of these markers suggesting them as fusion products of histiocytelike cells. Based on the results of the present study, on the basis of immunoreactivity of alpha-1 antitrypsin, alpha-1 antichymotrypsin and lysozyme, which are predominently in the histiocyte-like cells and to a lesser extent in the fibroblast-like cells, two populations of multinucleated giant cells, those with or without these markers may be encountered in GCT.
The mononuclear cells have been suggested to derive from the undifferentiated mesenchymal cells which then differentiate into osteoclasts [42] , or the undifferentiated supporting connective tissue of bone marrow [24] , the endothelial cells of blood vessels [35] , or from histiocytes [5] . Analyzing the results of the present study and our previous report [14] , we found that although giant cells showed heterogeneous immunoreactivity for vimentin, alpha-1 antitrypsin, alpha-1 antichymotrypsin and lysozyme, they showed uniformly intense immunoreactivity with monoclonal KP1 (CD 68) [14] and were unreactive Table3 .
Immunohistochemical results of GCT of bone for PCNA. These findings suggested that giant cells may not be tumor cells and originate from mononuclear phagocyte system. The presence of necrostic giant cells led us to believe that giant cells were in the end stage of maturation and their ultimate fate is cell death. There are two types of mononuclear cells. One type of its cell termed fibroblast-like cells were predominently in the GCT of bone, and showed intense immunoreactivity for vimentin and PCNA but were unreactive or rarely reactive for alpha-1 antitrypsin, alpha-1 antichymotrypsin, lysozyme and KP1. They were real tumor cells and might originate from mesenchymal tissue. The other type of mononuclear cells termed histiocyte-like cells were in the minority and showed immunoreactivity for vimentin, alpha-1 antitrypsin, alpha-1 antichymotrypsin, lysozyme and KP1. They may originate from mononuclear phagocyte system and are precursors of giant cells.
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